Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177.42NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.428NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.374NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.63 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.377NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.298NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.30.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.76NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.31NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.385NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.384NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.32NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.192NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.39.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
ME.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LE.1.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDR.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.49.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HV.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.15.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JD.1.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.441NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.509NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.293NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.225NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.637NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.39 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.26 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.103 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.3 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.18.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MB.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LE.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-18756.6US
LF.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MD.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LP.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.29.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.24.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.18.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LU.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used